Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma

Oncogene

Volumn 30, Issue 20, 2011, Pages 2319-2332

  Strub, T ^a   Giuliano, S ^b   Ye, T ^a   Bonet, C ^b   Keime, C ^a   Kobi, D ^a   Le Gras, S ^a   Cormont, M ^c   Ballotti, R ^b   Bertolotto, C ^b   Davidson, I ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

^c INSERM   (France)

Author keywords

cancer; DNA repair; metastasis; senescence

Indexed keywords

MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MYC PROTEIN;

ARTICLE; BINDING SITE; CELL LINEAGE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; GENETIC STABILITY; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MITOSIS; ONCOGENE; PRIORITY JOURNAL; RNA SEQUENCE; SENESCENCE;

BINDING SITES; CELL AGING; CELL LINE, TUMOR; CELL LINEAGE; DNA REPAIR; DNA REPLICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; GENOMIC INSTABILITY; HUMANS; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITOSIS; NEOPLASM METASTASIS; SKIN NEOPLASMS;

EID: 79956120349     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.612     Document Type: Article

References (52)

1. Abraham J, Lemmers B, Hande MP, Moynahan ME, Chahwan C, Ciccia A et al. (2003). Eme1 is involved in DNA damage processing and maintenance of genomic stability in mammalian cells. EMBO J 22: 6137-6147. (Pubitemid 37463256)
2. Artandi SE, DePinho RA. (2000). Mice without telomerase: what can they teach us about human cancer? Nat Med 6: 852-855. (Pubitemid 30644736)
3. Artandi SE, DePinho RA. (2010). Telomeres and telomerase in cancer. Carcinogenesis 31: 9-18.
4. Bentley DJ, Harrison C, Ketchen AM, Redhead NJ, Samuel K, Waterfall M et al. (2002). DNA ligase I null mouse cells show normal DNA repair activity but altered DNA replication and reduced genome stability. J Cell Sci 115: 1551-1561. (Pubitemid 34428711)
5. Bentley NJ, Eisen T, Goding CR. (1994). Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol Cell Biol 14: 7996-8006. (Pubitemid 24373548)
6. Bertolotto C, Busca R, Abbe P, Bille K, Aberdam E, Ortonne JP et al. (1998). Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol 18: 694-702. (Pubitemid 28063402)
7. Beuret L, Flori E, Denoyelle C, Bille K, Busca R, Picardo M et al. (2007). Up-regulation of MET expression by alpha-melanocyte-stimulating hormone and MITF allows hepatocyte growth factor to protect melanocytes and melanoma cells from apoptosis. J Biol Chem 282: 14140-14147. (Pubitemid 47100472)
8. Busca R, Berra E, Gaggioli C, Khaled M, Bille K, Marchetti B et al. (2005). Hypoxia-inducible factor 1\{alpha\} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells. J Cell Biol 170: 49-59. (Pubitemid 40994095)
9. Carreira S, Goodall J, Aksan I, La Rocca SA, Galibert MD, Denat L et al. (2005). Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature 433: 764-769. (Pubitemid 40292987)
10. Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, Hoek KS et al. (2006). Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 20: 3426-3439. (Pubitemid 44969160)
11. Carroll CW, Silva MC, Godek KM, Jansen LE, Straight AF. (2009). Centromere assembly requires the direct recognition of CENP-A nucleosomes by CENP-N. Nat Cell Biol 11: 896-902.
12. Cheeseman IM, Chappie JS, Wilson-Kubalek EM, Desai A. (2006). The conserved KMN network constitutes the core microtubule-binding site of the kinetochore. Cell 127: 983-997. (Pubitemid 44792248)
13. Chiaverini C, Beuret L, Flori E, Busca R, Abbe P, Bille K et al. (2008). Microphthalmia-associated transcription factor regulates RAB27A gene expression and controls melanosome transport. J Biol Chem 283: 12635-12642.
14. Delacroix L, Moutier E, Altobelli G, Legras S, Poch O, Choukrallah MA et al. (2010). Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic fibroblasts and embryonic stem cells. Mol Cell Biol 30: 231-244.
15. Du J, Widlund HR, Horstmann MA, Ramaswamy S, Ross K, Huber WE et al. (2004). Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell 6: 565-576. (Pubitemid 40017700)
16. Dynek JN, Chan SM, Liu J, Zha J, Fairbrother WJ, Vucic D. (2008). Microphthalmia-associated transcription factor is a critical tran-scriptional regulator of melanoma inhibitor of apoptosis in melanomas. Cancer Res 68: 3124-3132.
17. Fagiani E, Giardina G, Luzi L, Cesaroni M, Quarto M, Capra M et al. (2007). RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas. Cancer Res 67: 3064-3073. (Pubitemid 46724843)
18. Foltz DR, Jansen LE, Black BE, Bailey AO, Yates III JR, Cleveland DW. (2006). The human CENP-A centromeric nucleosome-associated complex. Nat Cell Biol 8: 458-469.
19. Garraway LA, Weir BA, Zhao X, Widlund H, Beroukhim R, Berger A et al. (2005a). 'Lineage addiction' in human cancer: lessons from integrated genomics. Cold Spring Harb Symp Quant Biol 70: 25-34. (Pubitemid 44124854)
20. Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S et al. (2005b). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436: 117-122. (Pubitemid 40966196)
21. Giuliano S, Cheli Y, Ohanna M, Bonet C, Beuret L, Bille K et al. (2010). Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas. Cancer Res 70: 3813-3822.
22. Goding CR. (2000a). Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev 14: 1712-1728. (Pubitemid 30602990)
23. Goding CR. (2000b). Melanocyte development and malignant melanoma. Forum (Genova) 10: 176-187. (Pubitemid 32060869)
24. Gomez-Baldo L, Schmidt S, Maxwell CA, Bonifaci N, Gabaldon T, Vidalain PO et al. (2010). TACC3-TSC2 maintains nuclear envelope structure and controls cell division. Cell Cycle 9: 1143-1155.
25. Goodall J, Carreira S, Denat L, Kobi D, Davidson I, Nuciforo P et al. (2008). Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of micro-phthalmia-associated transcription factor-negative melanoma cells. Cancer Res 68: 7788-7794.
26. Hoek KS, Eichhoff OM, Schlegel NC, Dobbeling U, Kobert N, Schaerer L et al. (2008a). In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res 68: 650-656. (Pubitemid 351206739)
27. Hoek KS, Schlegel NC, Brafford P, Sucker A, Ugurel S, Kumar R et al. (2006). Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res 19: 290-302. (Pubitemid 44015592)
28. Hoek KS, Schlegel NC, Eichhoff OM, Widmer DS, Praetorius C, Einarsson SO et al. (2008b). Novel MITF targets identified using a two-step DNA microarray strategy. Pigment Cell Melanoma Res 21: 665-676.
29. Hou L, Pavan WJ. (2008). Transcriptional and signaling regulation in neural crest stem cell-derived melanocyte development: do all roads lead to Mitf? Cell Res 18: 1163-1176.
30. Kim DS, Park SH, Park KC. (2004). Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation. Int J Biochem Cell Biol 36: 1482-1491.
31. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL et al. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015.
32. Kobi D, Steunou AL, Dembele D, Legras S, Larue L, Nieto L et al. (2010). Genome-wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene. Pigment Cell Melanoma Res 23: 404-418.
33. Koyanagi K, O'Day SJ, Gonzalez R, Lewis K, Robinson WA, Amatruda TT et al. (2006). Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients. Clin Cancer Res 12: 1137-1143. (Pubitemid 43342501)
34. Krebs A, Frontini M, Tora L. (2008). GPAT: retrieval of genomic annotation from large genomic position datasets. BMC Bio-informatics 9: 533.
35. Larribere L, Hilmi C, Khaled M, Gaggioli C, Bille K, Auberger P et al. (2005). The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis. Genes Dev 19: 1980-1985. (Pubitemid 41247956)
36. Levy C, Khaled M, Robinson KC, Veguilla RA, Chen PH, Yokoyama S et al. (2010). Lineage -specific transcriptional regulation of DICER by MITF in melanocytes. Cell 141: 994-1005.
37. McGill GG, Horstmann M, Widlund HR, Du J, Motyckova G, Nishimura EK et al. (2002). Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109: 707-718. (Pubitemid 34722267)
38. Moore R, Champeval D, Denat L, Tan SS, Faure F, Julien-Grille S et al. (2004). Involvement of cadherins 7 and 20 in mouse embryogenesis and melanocyte transformation. Oncogene 23: 6726-6735. (Pubitemid 39280004)
39. Neumann B, Walter T, Heriche JK, Bulkescher J, Erfle H, Conrad C et al. (2010). Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature 464: 721-727.
40. Nishimura EK, Suzuki M, Igras V, Du J, Lonning S, Miyachi Y et al. (2010). Key roles for transforming growth factor beta in melanocyte stem cell maintenance. Cell Stem Cell 6: 130-140.
41. Ouhtit A, Gaur RL, Abd Elmageed ZY, Fernando A, Thouta R, Trappey AK et al. (2009). Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146. Biochim Biophys Acta 1795: 130-136.
42. Pinner S, Jordan P, Sharrock K, Bazley L, Collinson L, Marais R et al. (2009). Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination. Cancer Res 69: 7969-7977.
43. Rothhammer T, Poser I, Soncin F, Bataille F, Moser M, Bosserhoff AK. (2005). Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res 65: 448-456.
44. Ruchaud S, Carmena M, Earnshaw WC. (2007). Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 8: 798-812. (Pubitemid 47462135)
45. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C et al. (1999). Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96: 701-712. (Pubitemid 29122812)
46. Schmit TL, Zhong W, Setaluri V, Spiegelman VS, Ahmad N. (2009). Targeted depletion of Polo-like kinase (Plk) 1 through lentiviral shRNA or a small-molecule inhibitor causes mitotic catastrophe and induction of apoptosis in human melanoma cells. J Invest Dermatol 129: 2843-2853.
47. Soengas MS, Lowe SW. (2003). Apoptosis and melanoma chemore-sistance. Oncogene 22: 3138-3151.
48. Steingrimsson E. (2008). All for one, one for all: alternative promoters and Mitf. Pigment Cell Melanoma Res 21: 412-414. (Pubitemid 351990965)
49. Tomkinson AE, Mackey ZB. (1998). Structure and function of mammalian DNA ligases. Mutat Res 407: 1-9. (Pubitemid 28157166)
50. Wang W. (2007). Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 8: 735-748. (Pubitemid 47429206)
51. Wu G, Lin YT, Wei R, Chen Y, Shan Z, Lee WH. (2008). Hice1, a novel microtubule-associated protein required for maintenance of spindle integrity and chromosomal stability in human cells. Mol Cell Biol 28: 3652-3662. (Pubitemid 351732902)
52. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE et al. (2008). Model-based analysis of ChIP-Seq (MACS). Genome Biol 9: R137.